Low-dose vs standard-dose everolimus combined with endocrine therapy in patients with HR-positive, HER2-negative advanced breast cancer: A multicenter real-world study

• DOI: 10.1016/j.asjsur.2024.11.135
• Publication Date: 2025-01-30T04:54:39Z
• Authors: Yichen Wang; Huiyun Lv; Yuhua Song; Die Sang; Zheng Lv; Tianyi Ma; Ning Li; Chen Song; Man Li
• Keywords: Everolimus